Michael J. McGinley, Presi, Biologic. & Pharm at HESKA CORP (HSKA), sold 12,141 shares at $60.07 ($729K) on 2016-11-07, disclosed to the SEC on 2016-11-09.
Open-market sale of $729k HSKA by Presi, Biologic. & Pharm. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.76 | 1,080 | $65K | 8.8% |
| 2 | $59.76 | 1,080 | $65K | 8.8% |
| 3 | $59.81 | 25 | $1K | 0.2% |
| 4 | $60.00 | 630 | $38K | 5.2% |
| 5 | $60.07 | 1,063 | $64K | 8.8% |
| 6 | $60.07 | 1,063 |
| $64K |
| 8.8% |
| 7 | $60.19 | 7,200 | $433K | 59.4% |
| Total | $60.08 avg | 12,141 | $729K | 100% |
| Filing → |
| HSKA | SELL | 2017-06-01 | $2.2M | — | Filing → |
| HSKA | SELL | 2016-05-10 | $219K | — | Filing → |
| HSKA | SELL | 2015-11-25 | $48K | — | Filing → |